Literature DB >> 17717922

[Effects of milkvetch root on neuro-endocrino-immune network in asthma model rat].

Jing-cheng Dong1, Fu-dong Zhao, Jin-yu Xie.   

Abstract

OBJECTIVE: To study the change and the effect of milkvetch root (MR) on neuro-endocrino-immune (NEI) network related indexes in repeated asthmatic attack model rats.
METHODS: Rats were randomly divided into five groups: the normal group (A), the model group (B), and the three treated groups (C, D, E) treated with low, medium and high dose of the MR by gastrogavage. The corticotropin releasing hormone (CRH) mRNA expression in hypothalamus was tested by Realtime-PCR, serum adrenocorticotropic hormone (ACTH) and corticosterone (CORT) were detected with radioimmunoassay, serum IL-6, IL-4, IFN-gamma determined with enzyme-linked immunosorbent assay, and the lung tissue pathology was examined by hematoxylin and eosin staining.
RESULTS: As compared with the normal group, in the rats 3 weeks after modeling, CRH mRNA expression, blood IFN-gamma and plasma ACTH were unchanged, serum level of CORT raised significantly (P<0.05), IL-6 and IL-4 showed an increasing trend but without significance. Low dose of MR could promote the production of serum CORT, and hight dose of MR could down-regulate the concentrations of IL-4 and IL-6 (P<0.01). No significant difference was found in comparison of pathological changes of lung tissue among the groups.
CONCLUSION: Rats suffered from repeated asthmatic attack have some disorders in indexes of NEI, MR could enhance the function of hypothalamic-pituitary-adrenal cortex axis and adjust the balance of Th1 and Th2 cytokines to alleviate the inflammation of asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717922

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Treatment of recurrent respiratory infection with Chinese drug therapy of Tonifying-Shen and solidifying superficiality--a clinical case report.

Authors:  Ya-bing Zhou; Min Wu; Jian-er Yu
Journal:  Chin J Integr Med       Date:  2011-11-19       Impact factor: 1.978

2.  Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial.

Authors:  Lei Wan; Jian Liu; Chuan-bing Huang; Yuan Wang; Xi Chen; Wan-dong Zhang; Gui-zhen Wang; Hai-xia Fan; Yao Ge; Rui-lian Chen; Yun-xiang Cao; Rui-kai Zong; Tian-yang Liu
Journal:  Chin J Integr Med       Date:  2016-01-27       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.